Suchergebnisse - "Tang, Mengling"

PubPharm (7)

1

Hypermethylation of tumor suppressor lncRNA MEF2C-AS1 frequently happened in patients at all stages of colorectal carcinogenesis

enthalten in: Clinical epigenetics | 2022

von Qian, S. | Lin, S. | Xu, X. | +10

2

Hypermethylation of tumor suppressor lncRNA MEF2C-AS1 frequently happened in patients at all stages of colorectal carcinogenesis

enthalten in: Clinical epigenetics | 2022

von Qian, S. | Lin, S. | Xu, X. | +10

3

Hypermethylation of tumor suppressor lncRNA MEF2C-AS1 frequently happened in patients at all stages of colorectal carcinogenesis

enthalten in: Clinical epigenetics | 2022

von Qian, S. | Lin, S. | Xu, X. | +10

4

Hypermethylation of tumor suppressor lncRNA MEF2C-AS1 frequently happened in patients at all stages of colorectal carcinogenesis

enthalten in: Clinical epigenetics | 2022

von Qian, S. | Lin, S. | Xu, X. | +10

5

Genome-Wide Methylation Profiling of lncRNAs Reveals a Novel Progression-Related and Prognostic Marker for Colorectal Cancer

enthalten in: Frontiers in oncology | 2021

von Lin, S. | Gu, S. | Qian, S. | +10

6

Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer

enthalten in: Clinical epigenetics | 2019

von Gu, S. | Lin, S. | Ye, D. | +11

7

Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer

enthalten in: Clinical epigenetics | 2019

von Gu, S. | Lin, S. | Ye, D. | +11

1
[1]